[go: up one dir, main page]

NO843055L - Fremgangsmaate ved fremstilling av cephalosporinderivater - Google Patents

Fremgangsmaate ved fremstilling av cephalosporinderivater

Info

Publication number
NO843055L
NO843055L NO843055A NO843055A NO843055L NO 843055 L NO843055 L NO 843055L NO 843055 A NO843055 A NO 843055A NO 843055 A NO843055 A NO 843055A NO 843055 L NO843055 L NO 843055L
Authority
NO
Norway
Prior art keywords
procedure
preparation
cephalosporine derivatives
cephalosporine
derivatives
Prior art date
Application number
NO843055A
Other languages
English (en)
Other versions
NO167292B (no
NO167292C (no
Inventor
Harold Alfred Crisp
Michael Wright
John Peter Turnbull
John Francis Oughton
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of NO843055L publication Critical patent/NO843055L/no
Publication of NO167292B publication Critical patent/NO167292B/no
Publication of NO167292C publication Critical patent/NO167292C/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/38Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof
    • C07D501/46Methylene radicals, substituted by nitrogen atoms; Lactams thereof with the 2-carboxyl group; Methylene radicals substituted by nitrogen-containing hetero rings attached by the ring nitrogen atom; Quaternary compounds thereof with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D501/14Compounds having a nitrogen atom directly attached in position 7
    • C07D501/16Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
    • C07D501/207-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
    • C07D501/247-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
    • C07D501/26Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group
    • C07D501/34Methylene radicals, substituted by oxygen atoms; Lactones thereof with the 2-carboxyl group with the 7-amino radical acylated by carboxylic acids containing hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO843055A 1983-07-29 1984-07-27 Fremgangsmaate ved fremstilling av cefuroksim 1-acetoksyetylester. NO167292C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838320521A GB8320521D0 (en) 1983-07-29 1983-07-29 Chemical process

Publications (3)

Publication Number Publication Date
NO843055L true NO843055L (no) 1985-01-30
NO167292B NO167292B (no) 1991-07-15
NO167292C NO167292C (no) 1991-10-23

Family

ID=10546505

Family Applications (1)

Application Number Title Priority Date Filing Date
NO843055A NO167292C (no) 1983-07-29 1984-07-27 Fremgangsmaate ved fremstilling av cefuroksim 1-acetoksyetylester.

Country Status (21)

Country Link
JP (1) JPH0613526B2 (no)
KR (1) KR910008377B1 (no)
AT (1) AT392470B (no)
AU (2) AU582121B2 (no)
BE (1) BE900241A (no)
CA (1) CA1265511A (no)
CH (1) CH662121A5 (no)
DE (1) DE3427828A1 (no)
DK (1) DK165505C (no)
ES (1) ES8601869A1 (no)
FI (1) FI76808C (no)
FR (1) FR2549837B1 (no)
GB (2) GB8320521D0 (no)
IE (1) IE57726B1 (no)
IL (1) IL72536A (no)
NL (1) NL8402372A (no)
NO (1) NO167292C (no)
NZ (1) NZ209046A (no)
PT (1) PT78985B (no)
SE (1) SE463263B (no)
ZA (1) ZA845830B (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US5063224A (en) * 1990-07-09 1991-11-05 Eli Lilly And Company R-cefuroxime axetil
IT1277426B1 (it) * 1995-08-03 1997-11-10 Acs Dobfar Spa Forma cristallina biodisponibile del cefuroxima axetil
CN1111537C (zh) * 1997-05-15 2003-06-18 第一制糖株式会社 高纯晶形头孢呋辛1-乙酰氧乙酯的制备方法
KR100228264B1 (ko) * 1997-08-02 1999-11-01 김선진 결정형 세푸록심 악세틸의 제조방법
CA2209868C (en) * 1997-08-15 2001-08-14 Bernard Charles Sherman Pharmaceutical compositions comprising cefuroxime axetil
IN186539B (no) * 1997-09-29 2001-09-29 Ranbaxy Lab Ltd
ES2171056T3 (es) * 1998-02-20 2002-08-16 Fako Ilaclari A S Procedimiento para la fabricacion de cefuroxima axetil cristalina soluble.
IN190849B (no) 2000-07-17 2003-08-23 Ranbaxy Lab Ltd
AT411996B (de) 2000-09-11 2004-08-26 Sandoz Ag Verfahren zur herstellung von cefuroxim in der form seines n-butylammoniumsalzes
ITMI20011763A1 (it) * 2001-08-10 2003-02-10 Antibioticos Spa Processo di preparazione di cefuroxime axelite ad elevata purezza
ITMI20011925A1 (it) * 2001-09-14 2003-03-14 Antibioticos Spa Metodo applicabile su scala industriale per la preparazione di cefuroxime axetile cristallino
TWI328006B (en) * 2003-12-26 2010-08-01 Nissan Chemical Ind Ltd Crystal form of quinoline compound and process for its production
CN100448879C (zh) * 2004-07-22 2009-01-07 北京化工大学 一种无定型头孢呋辛酯的制备方法
DE102005019458A1 (de) 2005-04-25 2006-10-26 Grünenthal GmbH Darreichungsform mit verbesserter Freisetzung von Cefuroximaxetil
CN118561870A (zh) * 2024-05-15 2024-08-30 广东立国制药有限公司 一种制备头孢呋辛酸的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1571683A (en) * 1976-02-16 1980-07-16 Glaxo Operations Ltd Ester derivatives of cefuroxime
CA1094545A (en) * 1976-02-16 1981-01-27 Michael Gregson Cephalosporin antibiotics
GB1598568A (en) * 1977-04-19 1981-09-23 Glaxo Lab Ltd Esters of(6r,7r)-3-carbamoyloxymethyl-7-((z)-2-(fur-2-yl)-2-methoxyiminoacetamido)-ceph-3-em-4-carboxylic acid
JPS577485A (en) * 1980-06-13 1982-01-14 Takeda Chem Ind Ltd Cephalosporin
YU44680B (en) * 1982-07-30 1990-12-31 Glaxo Lab Ltd Process for obtaining very pure amorphous form of cephuroxim axetile
GB8400024D0 (en) * 1984-01-03 1984-02-08 Glaxo Group Ltd Cephalosporin antibiotics

Also Published As

Publication number Publication date
DK165505B (da) 1992-12-07
ES534695A0 (es) 1985-11-01
FI843011L (fi) 1985-01-30
ES8601869A1 (es) 1985-11-01
CA1265511A (en) 1990-02-06
CH662121A5 (de) 1987-09-15
DE3427828A1 (de) 1985-02-14
NO167292B (no) 1991-07-15
ATA244484A (de) 1990-09-15
AT392470B (de) 1991-04-10
AU634965B2 (en) 1993-03-11
FR2549837A1 (fr) 1985-02-01
GB2145409B (en) 1987-02-18
IL72536A0 (en) 1984-11-30
GB2145409A (en) 1985-03-27
IE57726B1 (en) 1993-03-24
GB8419202D0 (en) 1984-08-30
FI843011A0 (fi) 1984-07-27
AU582121B2 (en) 1989-03-16
KR910008377B1 (ko) 1991-10-12
BE900241A (fr) 1985-01-28
SE8403897D0 (sv) 1984-07-27
SE8403897L (sv) 1985-01-30
NO167292C (no) 1991-10-23
DK366684A (da) 1985-01-30
JPH0613526B2 (ja) 1994-02-23
KR850001221A (ko) 1985-03-16
FI76808C (fi) 1988-12-12
DK165505C (da) 1993-04-19
ZA845830B (en) 1986-03-26
FR2549837B1 (fr) 1986-12-26
AU3660189A (en) 1989-10-05
PT78985B (en) 1986-10-23
NL8402372A (nl) 1985-02-18
IE841938L (en) 1985-01-29
DK366684D0 (da) 1984-07-27
AU3125684A (en) 1985-01-31
IL72536A (en) 1988-01-31
JPS6075484A (ja) 1985-04-27
PT78985A (en) 1984-08-01
NZ209046A (en) 1988-02-29
FI76808B (fi) 1988-08-31
SE463263B (sv) 1990-10-29
GB8320521D0 (en) 1983-09-01

Similar Documents

Publication Publication Date Title
NO841158L (no) Fremgangsmaate for fremstilling av 2-azetidin-4-substituerte forbindelser
NO843956L (no) Fremgangsmaate for fremstilling av karboksyalkenamido-cefalosporiner
NO811731L (no) Fremgangsmaate for fremstilling av imidazo-rifamycin-derivater
NO813678L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO851524L (no) Fremgangsmaate for fremstilling av fenetanolamin-forbindelser
DK95383A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
NO842214L (no) Fremgangsmaate for fremstilling av antibakterielle cefalosporinderivater.
NO843055L (no) Fremgangsmaate ved fremstilling av cephalosporinderivater
NO830988L (no) Fremgangsmaate ved fremstilling av stabiliserte pge-derivater
NO840434L (no) Fremgangsmaate ved fremstilling av benzothiazinderivater
NO844631L (no) Fremgangsmaate for fremstilling av tremasse
NO845207L (no) Fremgangsmaate for fremstilling av diaminopolyalkenyletere
NO844978L (no) Fremgangsmaate ved fremstilling av nye aminoguanidinderivater
DK86283A (da) Fremgangsmaade til fremstilling af cephalosporinderivater
NO823637L (no) Fremgangsmaate for fremstilling av eburnamoninderivater
NO820281L (no) Fremgangsmaate ved fremstilling av n-(halogenmethyl)-acylamider
NO833531L (no) Fremgangsmaate for fremstilling av 7-substituerte-3-vinyl-3-cefem-forbindelser
NO840865L (no) Fremgangsmaate til fremstilling av carbapenemderivater
NO845193L (no) Fremgangsmaate ved fremstilling av gonadoliberinderivater
NO844036L (no) Fremgangsmaate for fremstilling av cefalosporinderivater.
NO851758L (no) Fremgangsmaate ved fremstilling av isokinolinderivater
NO813477L (no) Fremgangsmaate for fremstilling av karbostyrilderivater
NO813814L (no) Fremgangsmaate for fremstilling av monoalkyletere av hydrokinonforbindelser
NO851638L (no) Fremgangsmaate ved fremstilling av iminothiazolidin-derivater
NO845016L (no) Fremgangsmaate ved fremstilling av substituerte spiropyridinderivater

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN JANUARY 2003